$CELG News Celgene stock price target cut to $120 from

New Post Public Reply Private Reply Replies (0) Message Board

Jan 29, 2016 at 12:14 PM

$CELG News

Celgene stock price target cut to $120 from $130 at Barclays 8:23 a.m. Today - Tomi Kilgore
Why this big baby of a market won’t calm down anytime soon 9:23 a.m. Jan. 28, 2016 - Victor Reklaitis
Celgene earnings miss as costs offset price hike 8:42 a.m. Jan. 28, 2016 - MarketWatch.com
Apple, Amazon headline crucial week for Wall Street quarterly results 6:21 a.m. Jan. 25, 2016 - Wallace Witkowski
Celgene started at outperform with $149 stock price target at Credit Suisse 8:16 a.m. Jan. 20, 2016 - Tomi Kilgore
10 biotech stocks to buy at ‘silly’ cheap prices 10:15 a.m. Jan. 18, 2016 - Michael Brush
As biotech stocks knife under their ‘Hillary’ low, analysts still say buy ’em 7:27 a.m. Jan. 12, 2016 - Victor Reklaitis
Celgene names new CEO, cuts 2015 outlook 1:45 p.m. Jan. 11, 2016 - MarketWatch.com
Shire agrees to buy Baxalta for $32 billion 8:49 a.m. Jan. 11, 2016 - MarketWatch.com
Shire agrees to buy Baxalta for $32 billion 8:16 a.m. Jan. 11, 2016 - MarketWatch.com
Celgene’s stock rockets as analysts cheer patent settlement 4:40 p.m. Dec. 23, 2015 - Tomi Kilgore
Dow posts triple-digit gain for third session in a row 4:27 p.m. Dec. 23, 2015 - Sara Sjolin
10 stocks that led the S&P 500 higher Wednesday 4:26 p.m. Dec. 23, 2015 - Philip van Doorn
Celgene shares jumps 8.4% in early trade as company settles patent suit 9:34 a.m. Dec. 23, 2015 - Mark DeCambre
Celgene shares lead S&P 500 gainers 9:34 a.m. Dec. 23, 2015 - Mark DeCambre
Celgene's stock surges 8.7% premarket after settlement of Revlimid patent litigation late Tuesday 8:59 a.m. Dec. 23, 2015 - Tomi Kilgore
Bulls ready to break out of the holiday quiet 8:45 a.m. Dec. 23, 2015 - Victor Reklaitis
Celgene shares rally on settlement of patent suit 5:00 p.m. Dec. 22, 2015 - Wallace Witkowski
Celgene shares rally 10% after patent litigation settled 4:45 p.m. Dec. 22, 2015 - Wallace Witkowski
AstraZeneca to buy 55% stake in Acerta Pharma 3:15 a.m. Dec. 17, 2015 - MarketWatch.com

SurModics' (SRDX) Q1 Earnings & Revenues Beat Estimates 34 min ago - Zacks.com
Stock Market News for January 29, 2016 10:10 a.m. Today - Zacks.com
Amgen Tops on Q4 Earnings & Revenues, Ups 2016 Outlook 9:05 a.m. Today - Zacks.com
Biotech ETF (IBB) Hits New 52-Week Low 8:59 a.m. Today - Zacks.com
European Ad Comm backs Bristol-Myers and AbbVie's elotuzumab for multiple myeloma 8:44 a.m. Today - Seeking Alpha
Cramer Likes T-Mobile - Cramer's Lightning Round (1/28/16) 7:16 a.m. Today - Seeking Alpha
Wall Street Breakfast: BOJ Goes Sub-Zero In The Heart Of Winter 6:57 a.m. Today - Seeking Alpha
What To Buy In This Biotech Sell-Off 6:46 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: I'm Buy, Buy, Buying T-Mobile US 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Market 'Trash' Will Make You Money 8:10 p.m. Jan. 28, 2016 - TheStreet.com
Celgene (CELG) Stock Plunged on Earnings Miss 4:52 p.m. Jan. 28, 2016 - TheStreet.com
'The Market Doesn't Know Where It's Headed' 4:02 p.m. Jan. 28, 2016 - TheStreet.com
Celgene Corporation's (CELG) CEO Robert J. Hugin on Q4 2015 Results - Earnings Call Transcript 3:31 p.m. Jan. 28, 2016 - Seeking Alpha
Stocks Back Near Highs in Unsettled Session 2:23 p.m. Jan. 28, 2016 - TheStreet.com
Incyte Halts Phase II Jakafi-Stivarga Combination Study 1:50 p.m. Jan. 28, 2016 - Zacks.com
Abbott Labs (ABT) Beats on Q4 Earnings, Lags on Revenues 11:43 a.m. Jan. 28, 2016 - Zacks.com
Celgene Earnings, Guidance Fail to Live Up to Investor Expectations 11:19 a.m. Jan. 28, 2016 - 247WallSt.com
Celgene Misses on Q4 Earnings, Reiterates 2016 Guidance 10:22 a.m. Jan. 28, 2016 - Zacks.com
Bristol-Myers Beats on Q4 Earnings, Provides 2016 Guidance 10:12 a.m. Jan. 28, 2016 - Zacks.com
Biotech Is the Cheapest Since 2011: 4 Top Stocks to Buy Now 9:39 a.m. Jan. 28, 2016 - 247WallSt.com

OncBioMune Patents a New Promising Approach to Chemotherapy 8:00 a.m. Jan. 28, 2016 - ACCESSWIRE
Technical Recap on Biotechnology Stocks -- Nektar Therapeutics, Novavax, Celgene, and Opko Health 8:01 a.m. Jan. 25, 2016 - ACCESSWIRE
Data Presented at ASCO GI Highlight the Feasibility of Second-Line Treatment in Patients with Metastatic Pancreatic Cancer Who Have Received First-Line Abraxane Plus Gemcitabine 3:31 p.m. Jan. 22, 2016 - BusinessWire - BZX
Be Counted! Campaign Brings Together the Psoriatic Arthritis Community to Increase Understanding of This Chronic, Autoimmune Disease 8:00 a.m. Jan. 22, 2016 - BusinessWire - BZX
Investigational Combinations Using an ABRAXANE and Gemcitabine Foundation Lead ASCO GI Pancreatic Cancer Research 7:30 a.m. Jan. 22, 2016 - BusinessWire - BZX
Covered Call Alerts For Chesapeake Energy, BlackBerry, Nike, AbbVie and Celgene Released By InvestorsObserver 9:31 a.m. Jan. 19, 2016 - PR Newswire - PRF
Organizational Changes Strengthen Leadership Teamand Position Celgene for Long-Term Growth 11:06 a.m. Jan. 11, 2016 - BusinessWire - BZX
Covered Call Alerts For Disney, Celldex Therapeutics, Shake Shack, Dow Chemical and Celgene Released By InvestorsObserver 9:31 a.m. Jan. 6, 2016 - PR Newswire - PRF
Celgene Corporation to Announce Fourth Quarter and Full-Year 2015 Results on January 28, 2016 7:30 a.m. Jan. 5, 2016 - BusinessWire - BZX
Celgene Corporation to Present at the 34th Annual J.P. Morgan Healthcare Conference 7:30 a.m. Jan. 4, 2016 - BusinessWire - BZX
Covered Call Alerts For Kinder Morgan, Rite Aid, Celgene, ConocoPhillips and Amazon.com Released By InvestorsObserver 9:31 a.m. Dec. 24, 2015 - PR Newswire - PRF
Oral REVLIMID® Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan 1:00 a.m. Dec. 21, 2015 - BusinessWire - BZX
Covered Call Alerts For Fitbit, Corning Inc., Celgene, CSX and Adobe Systems Released By InvestorsObserver 9:31 a.m. Dec. 14, 2015 - PR Newswire - PRF
BioSig Technologies, Inc. Issues Special Letter to Shareholders 8:01 a.m. Dec. 9, 2015 - Marketwired
Abstracts at San Antonio Breast Cancer Symposium Highlight ABRAXANE® as a Potential Backbone Therapy in Neoadjuvant and Triple-Negative-Breast Cancer 7:30 a.m. Dec. 9, 2015 - BusinessWire - BZX
Story Behind the Charts - Research on Celgene, United Continental Holdings, Yahoo! and Twitter 8:30 a.m. Dec. 8, 2015 - ACCESSWIRE
FDA Fast Track Designation Granted to Luspatercept for the Treatment of Patients with Lower-Risk Myelodysplastic Syndromes 7:00 a.m. Dec. 7, 2015 - BusinessWire - BZX
IMiD® Combination Therapies Form Backbone of Multiple Myeloma Research at ASH 7:00 a.m. Dec. 6, 2015 - BusinessWire - BZX
Celgene and Acceleron Announce New Results from an Investigational Study with Luspatercept in Myelodysplastic Syndromes Presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition 12:30 p.m. Dec. 5, 2015 - BusinessWire - BZX
Study of Bortezomib Added to Revlimid® and Dexamethasone Backbone Therapy Presented at ASH 10:53 a.m. Dec. 5, 2015 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Piedmont Orthopedics Expands Care in Henry County

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Airswift's Strategic Acquisition Boosts U.S. Energy Presence

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Guaranteed Roof Expands with EM Exteriors through LB Capital

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

WareSpace Expands Reach With $36.5M Acquisitions

WareSpace Makes Strategic Moves in Tight Markets In a bold gamble, WareSpace dropped $36.5 million to snag fresh industrial real estate in Miami Gardens, Florida, and South San Francisco, California. These aren't random picks, mind you. They're strategic grabs in markets where finding space ain't easier than winning the lottery. With more than 210 flexible units for small...

Bud Ecosystem Debuts AIOS, Aims to Slash Costs

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...

Foodcare Proves Effective in Reducing Blood Sugar Levels

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Omneky Integrates AI Growth Agent With Slack for Ads

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

American Savings Bank Surges 6% on NYSE Debut

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Donatos Targets Texas: Pushing Franchise Growth Limits

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...